热门出版物 - 学术资源搜索

h5 指数:47
h5 中位数:70

h5 指数是指在过去整整 5 年中所发表文章的 h 指数。h 指在 2018-2022 年间发表的 h 篇文章每篇至少都被引用过 h 次的最大值。隐藏

出版物的 h5 中位数，是指出版物的 h5 指数所涵盖的所有文章获得的引用次数的中位值。隐藏

#18 Diabetes

标题/作者	引用次数	年份
Prevalence of gestational diabetes mellitus in mainland China: A systematic review and meta‐analysis C Gao, X Sun, L Lu, F Liu, J Yuan Journal of Diabetes Investigation 10 (1), 154-162	357	2019
Japanese Clinical Practice Guideline for Diabetes 2016 M Haneda, M Noda, H Origasa, H Noto, D Yabe, Y Fujita, A Goto, T Kondo, ... Journal of Diabetes Investigation 9 (3), 657-697	340	2018
Japanese Clinical Practice Guideline for Diabetes 2019 E Araki, A Goto, T Kondo, M Noda, H Noto, H Origasa, H Osawa, ... Journal of Diabetes Investigation 11 (4), 1020-1076	321	2020
Prevalence of diabetes and its effects on stroke outcomes: A meta‐analysis and literature review LH Lau, J Lew, K Borschmann, V Thijs, EI Ekinci Journal of Diabetes Investigation 10 (3), 780-792	284	2019
Effects of probiotic supplements on insulin resistance in gestational diabetes mellitus: A double‐blind randomized controlled trial A Kijmanawat, P Panburana, S Reutrakul, C Tangshewinsirikul Journal of Diabetes Investigation 10 (1), 163-170	131	2019
Understanding the role of the gut ecosystem in diabetes mellitus W Aw, S Fukuda Journal of Diabetes Investigation 9 (1), 5-12	131	2018
Role of gut microbiota, bile acids and their cross‐talk in the effects of bariatric surgery on obesity and type 2 diabetes H Liu, C Hu, X Zhang, W Jia Journal of Diabetes Investigation 9 (1), 13-20	120	2018
Diabetic neuropathy and the sensory neuron: New aspects of pathogenesis and their treatment implications M Kobayashi, DW Zochodne Journal of Diabetes Investigation 9 (6), 1239-1254	119	2018
Sleep apnea and type 2 diabetes I Muraki, H Wada, T Tanigawa Journal of Diabetes Investigation 9 (5), 991-997	105	2018
Importance of physical evaluation using skeletal muscle mass index and body fat percentage to prevent sarcopenia in elderly Japanese diabetes patients Y Fukuoka, T Narita, H Fujita, T Morii, T Sato, MH Sassa, Y Yamada Journal of Diabetes Investigation 10 (2), 322-330	99	2019
Hyperglycemia in non‐obese patients with type 2 diabetes is associated with low muscle mass: The Multicenter Study for Clarifying Evidence for Sarcopenia in Patients with Diabetes Mellitus K Sugimoto, Y Tabara, H Ikegami, Y Takata, K Kamide, T Ikezoe, ... Journal of Diabetes Investigation 10 (6), 1471-1479	94	2019
Ipragliflozin improves mitochondrial abnormalities in renal tubules induced by a high‐fat diet S Takagi, J Li, Y Takagaki, M Kitada, K Nitta, T Takasu, K Kanasaki, ... Journal of Diabetes Investigation 9 (5), 1025-1032	94	2018
Sodium–glucose cotransporter 2 inhibitor‐induced changes in body composition and simultaneous changes in metabolic profile: 52‐week prospective LIGHT (Luseogliflozin: the Components of Weight Loss in Japanese Patients with Type 2 Diabetes Mellitus) Study T Sasaki, M Sugawara, M Fukuda Journal of Diabetes Investigation 10 (1), 108-117	93	2019
Effects of liraglutide, metformin and gliclazide on body composition in patients with both type 2 diabetes and non‐alcoholic fatty liver disease: A randomized trial WH Feng, Y Bi, P Li, TT Yin, CX Gao, SM Shen, LJ Gao, DH Yang, DL Zhu Journal of Diabetes Investigation 10 (2), 399-407	85	2019
Update in the epidemiology, risk factors, screening, and treatment of diabetic retinopathy KY Lin, WH Hsih, YB Lin, CY Wen, TJ Chang Journal of Diabetes Investigation 12 (8), 1322-1325	85	2021
Increased serum level and impaired response to glucose fluctuation of asprosin is associated with type 2 diabetes mellitus X Zhang, H Jiang, X Ma, H Wu Journal of Diabetes Investigation 11 (2), 349-355	84	2020
Metabolomics window into diabetic complications T Wu, S Qiao, C Shi, S Wang, G Ji Journal of Diabetes Investigation 9 (2), 244-255	84	2018
Postprandial glucose‐lowering effect of premeal consumption of protein‐enriched, dietary fiber‐fortified bar in individuals with type 2 diabetes mellitus or normal glucose tolerance JH Bae, LK Kim, SH Min, CH Ahn, YM Cho Journal of Diabetes Investigation 9 (5), 1110-1118	83	2018
Effects of canagliflozin on body composition and hepatic fat content in type 2 diabetes patients with non‐alcoholic fatty liver disease M Inoue, A Hayashi, T Taguchi, R Arai, S Sasaki, K Takano, Y Inoue, ... Journal of Diabetes Investigation 10 (4), 1004-1011	82	2019
Association of accumulated advanced glycation end‐products with a high prevalence of sarcopenia and dynapenia in patients with type 2 diabetes H Mori, A Kuroda, M Ishizu, M Ohishi, Y Takashi, Y Otsuka, S Taniguchi, ... Journal of Diabetes Investigation 10 (5), 1332-1340	79	2019

1 - 20

计算机程序会自动估算并确定日期和引用次数。